Feasibility study of postoperative intraperitoneal hyperthermochemotherapy by radiofrequency capacitive heating system for advanced gastric cancer with peritoneal seeding

International Journal of Hyperthermia

Volumn 23, Issue 6, 2007, Pages 493-500

  Mochiki, Erito ^a   Shioya, Mariko ^a   Sakurai, Hideyuki ^a   Andoh, Hiroyuki ^a   Ohno, Tetsuro ^a   Aihara, Ryusuke ^a   Asao, Takayuki ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Clinical trials whole body; Hyperthermochemotheraphy; Thermotron

Indexed keywords

CIMETIDINE; CISPLATIN; FLUOROURACIL; TS 1; UNCLASSIFIED DRUG;

ABDOMINAL DRAINAGE; ADULT; ADVANCED CANCER; ANOREXIA; ARTICLE; BLEEDING; CANCER RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; ELECTROMAGNETIC RADIATION; FEASIBILITY STUDY; FEMALE; GASTRECTOMY; HUMAN; HYPERTHERMIC THERAPY; INTESTINE PERFORATION; KIDNEY TUBULE DISORDER; LEUKOPENIA; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; PERITONEUM CANCER; POSTOPERATIVE CARE; PROGNOSIS; SIDE EFFECT; STOMACH CANCER; SURVIVAL RATE;

CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG THERAPY; FEASIBILITY STUDIES; FEMALE; GASTRECTOMY; HUMANS; HYPERTHERMIA, INDUCED; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM SEEDING; PERITONEAL NEOPLASMS; RADIO WAVES; STOMACH NEOPLASMS;

EID: 35549004852     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730701658234     Document Type: Article

References (37)

1. Nakajima, T., Harashima, S., Hirata, M. and Kajitani, T. (1978) Prognostic therapeutic values of peritoneal cytology in gastric cancer. Acta Cytol, 22, pp. 225-229.
2. Kiyasu, Y., Kaneshima, S. and Koga, S. (1981) Morphogenesis of peritoneal metastasis in human gastric cancer. Cancer Res, 41, pp. 1236-1239.
3. Yonemura, Y., Ninomiya, I., Kaji, M., Sugiyama, K., Fujimura, K., Sawa, T., Katayama, K., Tanaka, S., Hirono, Y. and Miwa, K. (1995) Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg, 19, pp. 450-455.
4. Levi, JA, Fox, RM, Tattersall, MH, Woods, RL, Thompson, D. and Gill, G. (1986) Analysis of a prospectively randomized comparison doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: Implication for future studies. J Clin Oncol, 4, pp. 1348-1355.
5. Overgaard, J. (1977) Effect of hyperthermia on malignant cells in vivo. Cancer, 39, pp. 2637-2646.
6. Hettinga, JVE, Konings, AWT and Kampinga, HH (1997) Reduction of cellular cisplatin resistance by hyperthermia-A review. Int J Hyperthermia, 13, pp. 439-457.
7. Fujimoto, S., Shrestha, RD, Kokubun, M., Kobayashi, K., Kiuchi, S., Konno, C., Ohta, M., Takahashi, M., Kitsukawa, Y., Mizutani, M., Chikenji, T. and Okui, K. (1990) Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer. Ann Surg, 212, pp. 592-596.
8. Fujimoto, S., Takahashi, M., Mutou, T., Kobayashi, K., Isawa, E., Sumida, M. and Ohkubo, H. (1997) Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined surgery. Cancer, 79, pp. 884-891.
9. ujimoto, S., Takahashi, M., Mutou, T., Kobayashi, K. and Toyosawa, T. (1999) Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer, 85, pp. 529-534.
10. Xu, DZ, Zhan, YQ, Sun, XW, Cao, SM and Geng, QR (2004) Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol, 18, pp. 2727-2730.
11. Yonemura, Y., Kawamura, T., Bandou, E., Takahashi, S., Sawa, T. and Matsuki, N. (2005) Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg, 92, pp. 370-375.
12. Stephens, AD, Alderman, R., Chang, D., Edwards, GD, Esquivel, J. and Sebbag, G. (1999) Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol, 6, pp. 790-796.
13. Abe, M., Hiraoka, M., Takahashi, M., Ono, K. and Nohara, H. (1982) Clinical experience with microwave and radiofrequency thermotherapy in the treatment of advanced cancer. Natl Cancer Inst Monogr, 61, pp. 411-414.
14. Abe, M., Hiraoka, M., Takahashi, M., Egawa, S., Matsuda, C., Onoyama, Y., Morita, K., Kakehi, M. and Sugahara, T. (1986) Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer, 58, pp. 1589-1595.
15. Gilly, FN, Cotte, E., Brigand, C., Monneuse, O., Beaujard, AC, Freyer, G. and Glehen, O. (2006) Quantitative prognostic indices in peritoneal carcinomatosis. Eur J Surg Oncol., 32, pp. 597-601.
16. Sugarbaker, PH (1995) Peritonectomy procedures. Ann Surg, 221, pp. 29-42.
17. Abe, M. and Hiraoka, M. (1985) Localized hyperthermia and radiation in cancer therapy; Review. Int J Radiat Biol, 47, pp. 347-359.
18. Tahara, M., Ohtsu, A. and Narikazu, B. (2001) Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with peritoneal dissemination: A retrospective study. Gastric cancer, 3, pp. 212-218.
19. Hall, JJ, Loggie, BW, Shen, P., Beamer, S., Case, LD, MaQuellon, R., Geisinger, KR and Levine, EA (2004) Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointestinal Surg, 8, pp. 454-463.
20. Son, CW, Shakil, A., Osborn, JL and Iwata, K. (1999) Tumor oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia, 15, pp. 79-107.
21. Storm, FK (1989) Clinical hyperthermia and chemotherapy. Radiol Clin N America, 27, pp. 621-627.
22. Kim, JY and Bae, HS (2001) A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). pp. 27-33.
23. Jones, RB, Myers, CE and Guarino, AM (1978) High volume intraperitoneal chemotherapy ("belly bath") for ovarian cancer. Pharmacologic basis and early results. Cancer Chemother Pharmacol, 5, pp. 1607-1612.
24. Glehen, O., Mohamed, F. and Gilly, FN (2004) Peritoneal carcinomatosis from digestive tract cancer: New management by cytoreductive surgery and intraperitoneal chemotherapy. Lancet Oncol, 5, pp. 219-228.
25. Takahashi, I., Emi, Y., Hasuda, S., Kakeji, Y., Maehara, Y. and Sugimachi, K. (2002) Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors. Surgery, 131, pp. S78-S84.
26. Hettinga, JVE, Konings, AWT and Kampinga, HH (1997) Reduction of cellular cisplatin resistance by hyperthermia - A review. Int J Hyperthermia, 13, pp. 439-457.
27. Sugimachi, K., Kuwano, H., Ide, H., Toge, T., Saku, M. and Oshiumi, Y. (1994) Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: A prospective randomized trial. Int J Hyperthermia, 10, pp. 485-493.
28. Wallner, KE and Li, GC (1987) Effect of drug exposure duration and sequencing on hyperthermia potentiation of mitomycin C and cisplatin. Cancer Res, 47, pp. 493-496.
29. Wallner, KE, Degregorio, MW and Li, GC (1986) Hyperthermia potentiation of cis-diamminedichloroplatinum (II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Res, 46, pp. 6242-6245.
30. Ohno, S., Siddik, ZH, Kido, Y., Zwelling, LA and Bull, JMC (1994) Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells. Cancer Chemother Pharmacol, 34, pp. 343-350.
31. Hettinge, JV, Lemstra, W., Meijer, C., Dam, WA, Uges, DRA and Konings, AWK (1997) Mechanism of hyperthermia potentiation of cisplatin action in cisplatin-sensitive and-resistant tumor cells. Br J Cancer, 75, pp. 1735-1743.
32. Diaz, JF and Andreu, JM (1993) Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: Reversibility, ligand stoichiometry, and competition. Biochemistry., 32, pp. 2747-2755.
33. Marchettini, P., Stuart, A., Mohamed, F., Yoo, D. and Sugarbaker, PH (2002) Docetaxel: Pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model. Cancer Chemother. Parmacol, 49, pp. 499-503.
34. Morgan Jr, RJ, Doroshow, JH, Synold, T., Lim, D., Shibata, S., Margolin, K., Schwarz, R., Leong, L., Somlo, G. and Twardowski, P. (2003) Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: Dose-limiting toxicity and pharmacokinetics. Clin Cancer Res, 9, pp. 5896-5901.
35. Yonemura, Y., Endou, Y., Bando, E., Kuno, K., Kawamura, T., Kimura, M., Shimada, T., Miyamoto, K., Sasaki, T. and Sugarbaker, PH (2004) Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer. Cancer Lett, 210, pp. 189-196.
36. Yonemura, Y., Bandou, E., Sawa, T., Yoshimitsu, Y., Endou, Y., Sasaki, T. and Sugarbaker, PH (2006) Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Eur J Surg Oncol, 32, pp. 661-665.
37. Shido, A., Ohmura, S., Yamamoto, K., Kobayashi, T., Fujimura, T. and Yonemura, Y. (2000) Dose hyperthermia induce peritoneal damage in continuous hyperthermic peritoneal perfusion?. World J Surg, 24, pp. 507-511.